CMT-3, a chemically modified tetracycline, inhibits pony metastases and delays the development of paraplegia in a rat model of prostate cancer

Marie G. Selzer, Baoqian Zhu, Norman L. Block, Bal L. Lokeshwar

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'CMT-3, a chemically modified tetracycline, inhibits pony metastases and delays the development of paraplegia in a rat model of prostate cancer'. Together they form a unique fingerprint.